UK markets open in 7 hours 51 minutes
NIKKEI 225
38,202.37 -632.73 (-1.63%) HANG SENG
18,313.86 -165.51 (-0.90%) CRUDE OIL
79.19 +0.20 (+0.25%) GOLD FUTURES
2,316.40 -5.90 (-0.25%) DOW
39,056.39 +172.13 (+0.44%) Bitcoin GBP
48,855.51 -1,007.27 (-2.02%)
Marinus Pharmaceuticals, Inc. (61Y.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 03:57PM CEST
| Previous close | 1.3700 |
| Open | 1.4800 |
| Bid | 1.3500 x N/A |
| Ask | 1.3900 x N/A |
| Day's range | 1.4800 - 1.6000 |
| 52-week range | 1.2000 - 10.2000 |
| Volume | |
| Avg. volume | 32 |
| Market cap | 92.949M |
| Beta (5Y monthly) | 0.89 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.4400 |
| Earnings date | 08 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 29.88 |
ZacksMarinus Pharmaceuticals (MRNS) Reports Q1 Loss, Lags Revenue Estimates
Marinus Pharmaceuticals (MRNS) delivered earnings and revenue surprises of 0% and 10.81%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Business WireMarinus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results
RADNOR, Pa., May 08, 2024--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today reported business highlights and financial results for the first quarter ended March 31, 2024.
ZacksWill Adherex Technologies Inc. (FENC) Report Negative Q1 Earnings? What You Should Know
Adherex Technologies (FENC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.